Deb Prabal, Deshpande G U, Rai Ramji
Officer Commanding, 2 Corps Blood Supply Unit, C/o 56 APO, Pune 411 040.
Reader, Dept of Pathology, Armed Forces Medical College, Pune 411 040.
Med J Armed Forces India. 2000 Oct;56(4):305-308. doi: 10.1016/S0377-1237(17)30215-0. Epub 2017 Jun 12.
Thirty cases of infiltrating duct carcinoma of the breast were studied for the expression of estrogen receptor (ER) and progesterone receptor (PR) status; p 53 protein mutation and c-erb B2 overexpression. The results were correlated with the morphological differentiation, as determined by the Nottingham's modification of the Bloom-Richardson system. Hormone receptor positivity was seen in 46.67% cases, whereas p 53 mutation and c-erb B2 overexpression were seen in 50.00% and 60.00% cases respectively. In grade II tumours receptor positivity, p53 mutation and c-erb B-2 overexpression were 57.15%, 42.85% and 52.38% respectively. The corresponding figures for grade III tumours were 33.33%, 83.33% and 66.67% respectively. As grade 1 comprised only 3 cases no statistical correlation could be observed. Thus we conclude that receptor positivity declined, whereas p 53 mutation and c-erb B-2 overexpression increased, with increase in tumour grade.
对30例乳腺浸润性导管癌患者的雌激素受体(ER)和孕激素受体(PR)状态、p53蛋白突变及c-erb B2过表达情况进行了研究。结果与根据诺丁汉对布鲁姆-理查森系统的改良所确定的形态学分化相关。46.67%的病例出现激素受体阳性,而分别有50.00%和60.00%的病例出现p53突变和c-erb B2过表达。在Ⅱ级肿瘤中,受体阳性、p53突变和c-erb B-2过表达分别为57.15%、42.85%和52.38%。Ⅲ级肿瘤的相应数字分别为33.33%、83.33%和66.67%。由于Ⅰ级仅包含3例病例,未观察到统计学相关性。因此我们得出结论,随着肿瘤分级增加,受体阳性率下降,而p53突变和c-erb B-2过表达增加。